Markets:

Overview

News

Currencies

International

Treasuries

HUTCHMED (China) Limited - American Depositary Shares (NQ:HCM)

14.35 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 1, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about HUTCHMED (China) Limited - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology

December 16, 2022

From Prenetics Limited

Via GlobeNewswire

Why Taboola Shares Are Trading Higher By Around 53%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗

November 28, 2022

Gainers Taboola.com Ltd. (NASDAQ: TBLA) shares gained 52.5% to $2.8050 after the company announced it entered into a 30-year exclusive commercial agreement with Yahoo.

Via Benzinga

Hutchmed Plans Strategic Focus Shift On Late-Stage Programs, Details Not Disclosed ↗

November 15, 2022

Via Benzinga

HUTCHMED Cancer Med Cuts Death Risk By 34% In Metastatic Colorectal Cancer ↗

September 08, 2022

Via Benzinga

Deutsche Bank ADR Investor Conference: Presentations Now Available for On-Demand Viewing

November 18, 2022

Company Executives Shared Vision and Answered Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Miniso Group, Monday.com And Other Big Gainers From Monday ↗

November 15, 2022

U.S. stocks closed lower on Monday, with the Dow Jones dropping more than 200 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

HUTCHMED Announces Strategy to Focus on Late-Stage Pipeline Regulatory Approvals

November 14, 2022

From HUTCHMED (China) Limited

Via GlobeNewswire

Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday ↗

November 15, 2022

Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus...

Via Benzinga

Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗

November 14, 2022

Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 14, 2022

Gainers Opiant Pharma (NASDAQ:OPNT) stock rose 118.3% to $20.74 during Monday's pre-market session. The market value of their outstanding shares is at $107.1 million. As per the press release, Q3...

Via Benzinga

360 DigiTech, HUTCHMED And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

November 14, 2022

U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Hutchmed-Lilly Partnered Gastric Cancer Drug Shows Mixed Results In Phase 3 Study ↗

November 14, 2022

HUTCHMED (China) Limited (NASDAQ: HCM) announced initial results from FRUTIGA Phase 3 trial of fruquintinib combined with paclitaxel in 703 Chinese patients with advanced gastric or gastroesophageal...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

November 14, 2022

Welcome back and get ready for the week with a breakdown of the biggest pre-market stock movers worth knowing about on Monday morning!

Via InvestorPlace

HUTCHMED Announces Positive Topline Result in Fruquintinib Phase III FRUTIGA Study in Second-Line Gastric Cancer in China

November 13, 2022

From HUTCHMED (China) Limited

Via GlobeNewswire

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 16th and 17th, 2022

November 09, 2022

From Virtual Investor Conferences

Via GlobeNewswire

HUTCHMED Initiates a Phase II/III Trial of Fruquintinib in Combination with Sintilimab for Advanced Renal Cell Carcinoma in China

October 27, 2022

From HUTCHMED (China) Limited

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 24, 2022

Gainers Applied Genetic Techs (NASDAQ:AGTC) shares moved upwards by 62.0% to $0.39 during Monday's pre-market session. The company's market cap stands at $26.3 million.

Via Benzinga

Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday ↗

November 08, 2022

Gainers

Via Benzinga

HUTCHMED Initiates a Phase II/III Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China

October 10, 2022

From HUTCHMED (China) Limited

Via GlobeNewswire

Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session ↗

November 07, 2022

Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870.

Via Benzinga

Nikola, Super Micro Computer And Other Big Losers From Monday ↗

September 20, 2022

U.S. stocks closed higher with the Dow Jones gaining around 197 points on Monday. Here is the list of some big stocks recording losses in the previous session.

Via Benzinga

Groupon, Spectrum Brands, Adobe And Other Big Losers From Thursday ↗

September 16, 2022

U.S. stocks closed lower with the Nasdaq 100 dropping around 200 points on Thursday. Here is the list of some big stocks recording losses in the previous session.

Via Benzinga

Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From Yesterday ↗

October 27, 2022

Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares climbed 180.2% to close at $4.82 on Wednesday after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the...

Via Benzinga

7 Chinese Stocks to Sell While You Still Can ↗

September 02, 2022

These Chinese stocks have had a rough outing at the stock markets of late, as their underlying businesses buckle under the economic pressure

Via InvestorPlace

Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday ↗

September 22, 2022

Gainers

Via Benzinga

Week in Review: Hansoh In-licenses Endometriosis/Fibroid Therapy in $170 Million Deal ↗

August 13, 2022

Other funding deals for drug discovery, R&D, gene editing.

Via Talk Markets

Recap of Tuesday's Biotech Catalysts - End Of the Day Summary ↗

August 09, 2022

Via Benzinga

Goldman Sachs Maintains Neutral Rating for HUTCHMED: Here's What You Need To Know ↗

August 09, 2022

Goldman Sachs has decided to maintain its Neutral rating of HUTCHMED (China) (NASDAQ:HCM) and raise its price target from $14.00 to $16.00. Shares of HUTCHMED (China) are trading down 5.74% over the...

Via Benzinga

Recap of Monday's Biotech Catalysts - End Of the Day Summary ↗

August 08, 2022

Via Benzinga

AstraZeneca's Tagrisso Doublet Therapy Shows 49% Response Rate In Lung Cancer Setting ↗

August 08, 2022

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.